Detalles de la búsqueda
1.
Effect of Project Orbis participation by the Swiss regulator on submission gaps, review times, and drug approval decisions between 2020 and 2022: a comparative analysis.
Lancet Oncol
; 25(6): 770-778, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754450
2.
Decision-making at Swissmedic, the Swiss regulatory agency, with a focus on (neo)adjuvant cancer treatments.
Oncology
; 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38442691
3.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Lancet Oncol
; 24(3): e121-e132, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858728
4.
Radiotherapy of the oldest old-feasibility and institutional analysis.
Strahlenther Onkol
; 196(8): 683-690, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32367454
5.
Radiomic biomarkers for head and neck squamous cell carcinoma.
Strahlenther Onkol
; 196(10): 868-878, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495038
6.
Feasibility and Usability Aspects of Continuous Remote Monitoring of Health Status in Palliative Cancer Patients Using Wearables.
Oncology
; 98(6): 386-395, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31336377
7.
CT radiomics and PET radiomics: ready for clinical implementation?
Q J Nucl Med Mol Imaging
; 63(4): 355-370, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527578
8.
Influence of inter-observer delineation variability on radiomics stability in different tumor sites.
Acta Oncol
; 57(8): 1070-1074, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29513054
9.
Intra- and inter-fraction breath-hold variations and margins for radiotherapy of abdominal targets.
Phys Imaging Radiat Oncol
; 28: 100509, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-38045640
10.
Toward Data-Driven Radiation Oncology Using Standardized Terminology as a Starting Point: Cross-sectional Study.
JMIR Form Res
; 6(1): e27550, 2022 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35044315
11.
Improved Survival Prediction by Combining Radiological Imaging and S-100B Levels Into a Multivariate Model in Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibition.
Front Oncol
; 12: 830627, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35494048
12.
Long-term cancer survivors treated with multiple courses of repeat radiation therapy.
Radiat Oncol
; 16(1): 208, 2021 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717664
13.
Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types.
Br J Radiol
; 94(1120): 20200947, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544646
14.
Targeting Treatment Resistance in Head and Neck Squamous Cell Carcinoma - Proof of Concept for CT Radiomics-Based Identification of Resistant Sub-Volumes.
Front Oncol
; 11: 664304, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34123824
15.
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Radiat Oncol
; 16(1): 217, 2021 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775998
16.
Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy.
Phys Imaging Radiat Oncol
; 17: 43-46, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33898777
17.
Multimodal treatment strategies for colorectal liver metastases.
Swiss Med Wkly
; 151: w20390, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631027
18.
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
Radiat Oncol
; 16(1): 84, 2021 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947429
19.
Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study.
J Palliat Med
; 23(5): 678-685, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31873052
20.
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition.
Clin Cancer Res
; 26(16): 4414-4425, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253232